America Great Health reported significant financial developments in its latest quarterly filing for the period ending September 30, 2024. The company achieved sales of $140,126, a substantial increase from $13,808 in the same period last year, primarily attributed to the launch of new products. The cost of goods sold also rose to $11,335 from $177, leading to a gross profit of $128,791 compared to $13,631 in the prior year. Despite this increase in revenue, the company recorded a net loss of $146,967, slightly improved from a loss of $156,980 in the previous year, reflecting reduced payroll and professional expenses.
In terms of operational metrics, America Great Health's total current assets decreased to $216,642 from $225,479 as of June 30, 2024. The company’s cash balance fell to $49,031 from $54,943, while accounts receivable dropped to $36,900 from $55,100. The inventory, however, increased significantly to $119,116 from $83,141, indicating a strategic buildup of stock likely in anticipation of future sales. The company’s total liabilities rose to $5,694,913 from $5,635,077, contributing to a shareholders' deficit of $5,389,271, slightly improved from $5,311,599.
Strategically, America Great Health has been focusing on expanding its product offerings and enhancing its market presence. The company has engaged in various financing activities, including the issuance of common stock, which generated $68,000 in cash during the quarter. The company’s operational strategy appears to be centered on leveraging new product launches to drive sales growth, although it continues to face challenges related to its overall financial health and liquidity.
Looking ahead, America Great Health's management has expressed concerns regarding its ability to continue as a going concern, given the recurring net losses and significant shareholders' deficit. The company plans to rely on loans and advances from its majority shareholder to meet its cash needs over the next twelve months. The management is actively seeking additional capital to support ongoing operations and achieve profitability, although there is no assurance that these efforts will be successful.
Overall, while America Great Health has made strides in increasing its sales and product offerings, it continues to navigate a challenging financial landscape, with a focus on securing necessary funding and improving operational efficiencies to stabilize its financial position.
About America Great Health
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.